SINTX Technologies Inc

SINTX recorded a 199% revenue increase in the second quarter of 2026 to $452,000 and improved its gross margin to 61.5%, while net loss widened to $2.7 million. The company reported initial commercial revenues for the SINAPTIC-Wedge system and orders from contract manufacturing customers of about $3.2 million. The stock finished the regular session slightly higher but declined after hours as investors weighed continued losses, high cash burn (cash $3.6 million) and doubts about the company’s ability to continue as a going concern. Management guidance sees revenue of $0.9–1.1 million for Q3 2026 and $1.0–1.3 million for Q4, and the company emphasized additional financing needs and ongoing execution risks. » Altro su de.investing.com

SINTX Technologies has signed a supply agreement with Evonik for the industrial production of its patented silicon nitride‑PEEK (SiN/PEEK) composite for AI‑assisted additive manufacturing of patient‑specific implants. Evonik will produce the scalable composite filament to SINTX specifications, enabling SINTX to begin immediate manufacture of 3D‑printed vertebral body replacement implants and other indications. SINTX highlights the material’s antipathogenic surface properties, osteogenic potential and improved imaging, and intends to use it to support regulatory approvals and humanitarian applications. » Altro su finanzen.net

SINTX Technologies has signed a private-label agreement to supply the biologic OsseoSculpt, intended to complement the FDA‑cleared SINAPTIC Foot & Ankle Osteotomy Wedge System. The company reports initial commercial revenue from OsseoSculpt in Q3 2025 and plans a limited rollout at early‑adopter sites with a broader US launch in Q1 2026. In parallel, SINTX received 510(k) clearance for the SINAPTIC wedge system, a Notice of Allowance for an anti‑pathogenic silicon nitride technology, and raised about $3.8 million through option exercises, but remains under profitability pressure with negative EBITDA and sharply declining revenues. » Altro su de.investing.com